About
B-Temia is a Canadian bio-robotics technology company founded in 2010, focused on developing powered assistive devices that enhance mobility and autonomy for individuals with biomechanical impairments. The company aims to help people regain their independence with dignity and confidence, improving their overall quality of life. B-Temia's core technology, Dermoskeleton™, powers its flagship products, including Keeogo™, a medical knee exoskeleton designed for individuals facing mobility challenges due to conditions like Parkinson’s disease and osteoarthritis. Keeogo™ is approved for use in Canada, Europe, and the United States. Another product, ONYX™, is tailored for military applications, developed in partnership with Lockheed Martin to support soldiers in the field. The company serves various markets, including medical rehabilitation, military, and industrial sectors, and has expanded its global presence through partnerships, such as its collaboration with Wistron Corporation to commercialize Keeogo™ in Asia. B-Temia is recognized as a leader in the human augmentation market, combining innovative robotics with practical applications.
Technologies
Keywords
Company Information
-
Employees 16
-
Founded 2010
-
Total Funding $6925317
Location
4780 Rue St-Felix, Saint-Augustin-de-Desmaures, Quebec, Canada, G3A 2J9